Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:39 PM
Ignite Modification Date:
2025-12-24 @ 11:39 PM
NCT ID:
NCT06569251
Eligibility Criteria:
Inclusion Criteria:
1. Delivery of a signed and dated informed consent form.
2. Declared willingness to comply with all study procedures and availability during the duration of the study.
3. Pregnant patient with 20 or more weeks of gestation determined by USG with clinically diagnosed threat of preterm labor (defined as uterine contractions with sufficient progressive frequency and intensity that allow dilation of the cervix before the 37th week of gestation).
4. Pregnant patient admitted and birth in the Maternal and Child Hospital, Labor and Delivery room. Part.
5. Delivery carried out at the Teaching Hospital.
6. Patient with a diagnosis of premature rupture of membranes under conservative management.
7. patient must know how to read and write
8. Possess a cell phone or some other means of communication.
9. Residing in the city of Tegucigalpa, Honduras.
Exclusion Criteria:
1. Patients under 18 years of age.
2. Patient with diagnosed psychiatric illnesses.
3. Pregnant patient with threat of preterm birth who is also diagnosed with preeclampsia with data of severity and intrauterine growth restriction.
4. Pregnant patient with threat of preterm birth who is also diagnosed with premature rupture of membranes.
5. Pregnant patient with threat of preterm birth who is also diagnosed con corioamnionitis.
6. Pregnant patient with threat of preterm birth who is also diagnosed with acute abdomen.
7. Major fetal malformations
8. Fetal death
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
45 Years
Study:
NCT06569251
Study Brief:
Protocol Section:
NCT06569251